Skip to content
The Nexus
DossierENTITY

Basel

Coverage of Basel in the Nexus archive.

Earliest in view: Apr 23 · 05:15 UTCMost recent: Jun 27 · 18:18 UTC
Co-mentioned in this coverage
Recent coverage
  • WORLDJun 27 · 18:18 UTCWPLG LOCAL 10 MIAMI
    Central Europe sizzles as heat records are smashed in Switzerland, Denmark and Czech Republic

    Central Europe experienced record-breaking heat, with temperatures exceeding 37°C in Denmark, 38.8°C in Switzerland, and 40.8°C in the Czech Republic. Infrastructure damage, transportation disruptions, and health emergencies, including a nursing home evacuation and hospital overloads in France, were reported due to the extreme weather.

  • WORLDJun 27 · 15:23 UTCAP NEWS
    Central Europe sizzles as heat records are smashed in Switzerland, Denmark and Czech Republic

    Central Europe experienced record-breaking heat in June 2026, with temperatures reaching 37°C in Denmark, 38.8°C in Switzerland, and 40.6°C in the Czech Republic. The heatwave caused infrastructure damage, including melted Autobahn concrete in Germany, disrupted rail travel, and led to a nursing home evacuation. Hospitals in France faced severe pressure from heat-related emergencies.

  • BUSINESSApr 27 · 15:58 UTCBLOOMBERG
    Chemical Firm Arxada Gets Key Lender Support for Debt Extension

    Chemical firm Arxada has received key lender support to extend its debt, which could help stabilize its financial position. The development is based in Basel, though specific lender details are not provided in the article.

  • HEALTHApr 24 · 20:36 UTCTHE GUARDIAN WORLD
    Mother ends life at Swiss clinic four years after son’s death

    Wendy Duffy, a 56-year-old mother, ended her life at the Pegasos clinic in Basel, Switzerland, four years after her son Marcus died. The assisted dying bill in England and Wales failed to pass, highlighting ongoing legal debates around the issue.

  • BUSINESSApr 23 · 05:15 UTCBLOOMBERG
    Roche First-Quarter Sales Drop, Hurt by Copycats and Currencies

    Roche Holding AG reported a first-quarter sales decline, primarily due to competition from generic drugs (copycats) and adverse currency effects. The company's headquarters in Basel, Switzerland, was highlighted in the report.

Basel · Dossier · The Nexus